Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD

INTRODUCTION: Long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are established maintenance bronchodilator treatments for chronic obstructive pulmonary disease (COPD) with the potential to increase heart rate (HR) and impact blood pressure (BP). While previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreas, Stefan, McGarvey, Lorcan, Bothner, Ulrich, Trampisch, Matthias, de la Hoz, Alberto, Fležar, Matjaz, Buhl, Roland, Alter, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428407/
https://www.ncbi.nlm.nih.gov/pubmed/32848379
http://dx.doi.org/10.2147/COPD.S246348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428407/
https://www.ncbi.nlm.nih.gov/pubmed/32848379
http://dx.doi.org/10.2147/COPD.S246348

Ejemplares similares